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was investigated for both sliding window and VMAT 
techniques (RapidArcTM technology). 
Results: Dynalog files premit to predict the number of 
tolerance faults as a function of the tolerance value, with 
accurate predictions for low incidences of tolerance faults. 
All MLCs presented a very similar behavior, with no 
significant difference between the Millennium120 and the 
HD120 models. In sliding window techniques the number of 
beams with an incidence of hold-offs >1% rapidly decreases 
for a tolerance ~1.5 mm. It is to remark that most of the 
beam hold-offs (>97%) produced in sliding window beams with 
the 2 mm tolerance were caused by the maximum leaf speed 
specification not being properly taken into account in the 
treatment planning process. In VMAT techniques the number 
of tolerance faults sharply drops for tolerances around 2 mm. 
For a tolerance of 2.5 mm less than 0.1% of the VMAT arcs 
presented tolerance faults. 
 
Conclusions: Dynalog analysis provides a feasible method to 
investigate the optimal tolerance for MLC positioning in 
dynamic fields. In sliding window treatments the tolerance of 
2 mm was found to be adequate. However, to further 
guarantee the accuracy of treatment delivery, this tolerance 
could be reduced to 1.5 mm. In VMAT treatments the 
typically used 5 mm tolerance is excessively high. Instead, a 
tolerance of 2.5 mm is recommended.  
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Purpose/Objective: To replace the multitude of devices with 
a singular one that measures and records all mechanical, 
optical and relative dosimetry parameters associated with 
the monthly quality assurance (QA) of external beam therapy 
and high dose rate (HDR) brachytherapy systems. 
Materials and Methods: The QA system consists of a novel 
multi-mirror assembly in a light-tight housing which directs 
images from a receptor plane for capture with an in-line 1.4 
mega-pixel CCD camera. The in-line camera simplifies cable 
management and is shielded against scattered and leakage 
radiation. The entire housing with the in-line camera is 
rotated under computer control to any desired position. A 
single 25 cm x 25 cm phosphor screen is used as the image 
receptor and is typically positioned at the machine iso-
center. Optical images of the room lasers, light field and 
optical distance indicator are transmitted through the semi-
transparent phosphor screen for capture by the camera. The 
CCD is operated with 0.5 sec integration for optical light 
imaging. For the QA of external beam radiation, a buildup 
plate is inserted on top of the phosphor screen which 
produces a 2D image of an irradiating x-ray or electron field 
for QA analysis. The CCD is operated with 20 sec integration 
for radiation imaging, appropriately corrected for dark 
current background. Relative QA of dosimetry parameters, 
such as flatness and symmetry, are made with respect to 
baseline measurements. Beam energy constancy checks were 
made using brass buildup plates with island filters. For the 
QA of HDR brachytherapy system, applicators are secured on 
surface of the phosphor screen where the dwelled positions 
of source are verified using the resultant fluorescence image.  
Results: The system provides high spatial resolution for QA at 
0.24 mm x 0.24 mm per pixel. The positioning accuracy of 
the multi-leaf collimator was determined to be well within 1 
mm using the picket fence method. The isocentricities of the 
collimator and table rotation were determined by the centers 
of mass (COM) of the resultant images of a small 2 cm x 2 cm 
rotated x-ray beam. The same COM method was used to 
determine the gantry radiation isocentricity by rotating the 
QA system in alignment with the gantry for radiation. The 
resultant 3D gantry radiation isocenter information cannot be 
measured with film star-shot. Beam energy constancy based 
on pixel intensities were within 1% for repeated runs. 
Planned and delivered dwell positions of HDR sources agreed 
to 1.2 mm +/- 0.5 mm. 
Conclusions: A single device has been successfully developed 
to unify all mechanical, optical and radiation QA 
measurements of the accelerator per recommendations of 
TG-142 of the AAPM. The time spent is reduced by two-third. 
The system can be applied for HDR source positioning QA. 
Most important, the system records and documents optical 
measurements that are now only evaluated visually which 
will strengthen the confidence for safe patient treatment.  
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Purpose/Objective: To systematically assess VMAT delivery 
accuracy and efficiency by means of log file based quality 
assurance using a dynamic benchmark test plan.  
Materials and Methods: The VMAT test plan was generated 
using iComCAT (Elekta) and delivered at 18 Elekta linacs (13 
Synergy with MLCi2, 5 Agility) in Friedrichshafen, Amsterdam, 
Vienna and Feldkirch. For the test plan, square field shapes 
with varying field size (0.5x0.5cm2 to 24x24cm2) and a full 
gantry rotation were generated. Control points were 
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composed to vary dose rate, MLC positions, jaw and gantry 
speed to push dynamic parameters to the limit.  
Planned vs. actual leaf positions, jaws and gantry were 
quantified by analyzing the linac's log files. A delivery 
robustness index was introduced by means of the ratio of the 
planned MLC path versus the actual MLC path. Delivery 
efficiency in terms of dose rate stability and delivery time 
was investigated for each of the 18 linacs.  
Dosimetric verification was performed at 3 institutes using 
the OCTAVIUS 4D system and Verisoft 6.0 (PTW) to examine 
intra-linac consistency. Relative dose differences were 
assessed by mean gamma (1mm/1%) for each control point 
and compared to the results of the log file evaluation. 
Results: Fourteen linacs delivered the benchmark plan 
without difficulty, while 4 linacs failed due to delivery 
termination. The linac inhibits were mostly related to dose 
rate and beam steering servo dysfunctions in rotational 
mode. Other inhibits were caused by tolerances that were set 
too tight. 
The mean leaf error during plan delivery was 0.28±0.15mm 
for all linacs. The maximum errors for MLC and jaw positions 
were found at control points where the moving direction 
reversed, where deviations up to 7.4mm were detected. 
Delivery robustness varied from 0.83 to 1.01, indicating the 
extent of MLC repositioning and overtravel. This index was 
found to correlate well with delivery time (R²=0.95), which 
varied from 80s to 128s, depending on the linac's ability to 
keep a constant low dose rate for arc segments demanding 
maximum leaf speed.  
Dosimetric evaluation of delivery robustness for plans 
including all control points resulted in a mean gamma of 
0.68±0.19, indicating very accurate plan reproducibility. 
Control point resolved analysis correlated very well with log 
file analysis, 3D gamma value display (fig.1) also reveals 
information about the error of mapped MLC leaf pair 
numbers. 
 
Conclusions: The test plan and procedure was found to be a 
valuable VMAT benchmark test to identify linac related 
malfunctions in dynamic mode. Delivery robustness was found 
to be related to dose rate stability and MLC overtravel. 
Overall, MLC errors were comparable even though delivery 
time and robustness varied considerably. The dosimetric 
evaluation provides strong evidence that log file indicated 
errors correlate with delivery accuracy for small arc 
segments. Log files contain valuable data to be used for 
acceptance testing of rotational techniques and proactive 
linac QA. 
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Purpose/Objective: On December 18, 2013 we treated our 
first patient with the single room Mevion S250 Proton Therapy 
System. This followed seven months of acceptance testing 
and commissioning, including; dosimetric data acquisition, 
safety checks, establishing quality assurance programs, 
mechanical and imaging checks, beam modeling validation, 
etc. 
Materials and Methods: The Mevion S250 possesses a 
compact synchro-cyclotron attached to a gantry due to its 
small size (1.8m diameter) and light weight (22 tons). The 
delivery system works in combination with a 6D robotic couch 
for allowing beam trajectories of any given beam angle. The 
system currently customizes beams using passive scattering 
and provides 3D-2D imaging via fixed x-rays, with a portable 
CT forthcoming for volumetric matching. Our treatment 
planning system is Varian Eclipse, V11, for which beam 
modeling and validation comprised the most of the 
commissioning time. The electronic medical record system is 
Elekta’s MOSIAQ 2.5, which provides connectivity to the 
Mevion System, for setup, imaging and treatment. 
Results: The treatment planning modeling and validation met 
a set gamma index of 1%, 1mm for 98% or more of points 
sampled. The image system quality was tested to be equal or 
better than current onboard imaging systems in our clinic. 
The neutron dose was measured to be < 1.0 mSv)/Gy for most 
clinical fields tested, alleviating concerns for pediatric 
treatments. The measured isocentricity of the gantry and 
couch was measured to be 0.5 and 0.6mm, respectively. The 
QA program developed includes a 30 minute procedure; 
including checks for; couch isocentricity, interlocks, warning 
indicators, imaging, and most importantly, dosimetric checks 
for three of 24 options. Daily, we measure output, 
modulation flatness, range, field symmetry, and distal 
falloff, all with a single exposure per option. In terms of 
machine operation and reliability, the uptime for the 
majority of treatment months was at least 95%. Clinical start 
up over the first 11 months included a variety of the first 100 
cases, predominantly; adult CNS, pediatrics, including Cranial 
Spinal (CS), lung, pelvis, liver, and H&N. Thorax patients 
receive weekly scans to ascertain if new adaptive plans are 
needed. We are currently treating 18-22 patients per day, 
with the caseload depending on the number of anesthesia 
and CSI cases. Currently all adult patients are being planned 
with a backup treatment plan for IMRT or conventional 
therapy. This is performed in order to; make proper and 
honest planning comparisons, as a backup plan in case the 
proton machine has significant downtime, and for billing 
justification purposes. 
Conclusions: The Mevion S250 has added a vital delivery 
option to compliment other treatment machines within our 
National Cancer Institute (USA) Comprehensive Cancer 
Center. 
